2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

InFlectis Competitors or Alternatives

InFlectis's top competitors include NMD Pharma, PepGen and Scholar Rock.

Unlock 20 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

InFlectis's company profile

Philippe Guedat

President & CEO

90/100
1 - 25
$7.7M
$5M - 25M
  • $7.7M
    $5M - 25M
  • 1 - 25
    $7.7M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $7.7M
  • $5M - 25M
View ProfileView
1
InFlectis's Competitor - NMD Pharma logo

Thomas Holm Pedersen

CEO

90/100
25 - 100
$169.7M
$100K - 5M
  • $169.7M
    $100K - 5M
  • 25 - 100
    $169.7M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $169.7M
  • $100K - 5M
View ProfileView
2
InFlectis's Competitor - PepGen logo

James McArthur

President & CEO

90/100
30
$269.1M
  • $269.1M
  • 30
    $269.1M
  • 90/100
  • 30
  • $269.1M
View ProfileView
3
InFlectis's Competitor - Scholar Rock logo

Jay Backstrom

President & CEO

90/100
140
$531.1M
$33.2M
  • $531.1M
    $33.2M
  • 140
    $531.1M
  • $33.2M
  • 90/100
  • 140
  • $531.1M
  • $33.2M
View ProfileView
4
InFlectis's Competitor - ProMIS Neurosciences logo

Neil K. Warma

Interim-CEO

82/100
7
$81.1M
$364.4M
  • $81.1M
    $364.4M
  • 7
    $81.1M
  • $364.4M
  • 82/100
  • 7
  • $81.1M
  • $364.4M
View ProfileView
5
InFlectis's Competitor - ArQule logo

Paolo Pucci

CEO

87/100
1 - 25
$55.2M
$5M - 25M
  • $55.2M
    $5M - 25M
  • 1 - 25
    $55.2M
  • $5M - 25M
  • 87/100
  • 1 - 25
  • $55.2M
  • $5M - 25M
View ProfileView
InFlectis' top 23 competitors are NMD Pharma, PepGen, Scholar Rock, Treventis, ProMIS Neurosciences, ArQule, Biodesy, Unchained Labs, Alzheon, AbbVie, BioVersys, Amgen, Novartis, Alzinova, Juno Therapeutics, Lilly, Eisai, NexImmune, Cybrexa, Grifols, CTI BioPharma, KalGene Pharmaceuticals and Aura. Together they have raised over 18.0B between their estimated 215.7K employees. InFlectis's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 10.2B. InFlectis has 20 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 9,805.

InFlectis VS NMD Pharma

NMD Pharma is perceived as one of InFlectis's biggest rivals. NMD Pharma is headquartered in Aarhus, Central Jutland, and was founded in 2015. Like InFlectis, NMD Pharma also operates in the Biotechnology industry. NMD Pharma generates 49% the revenue of InFlectis.

InFlectis VS PepGen

PepGen is one of InFlectis's top competitors. PepGen is a Public company that was founded in 2018 in Cambridge, Massachusetts. Like InFlectis, PepGen also operates in the Biotechnology field. Compared to InFlectis, PepGen has 10 more employees.

InFlectis VS Scholar Rock

Scholar Rock has been one of InFlectis's top competitors. Scholar Rock was founded in 2012 in Cambridge, Massachusetts. Like InFlectis, Scholar Rock also works within the Biotechnology field. Scholar Rock generates $26.7M more revenue than InFlectis.

Looking for similar companies to InFlectis?

Similar Companies

Biotechnology companies in Nantes

See 12 companies 
Pharmaceuticals & Biotechnology companies in Nantes

See 15 companies 
Biotechnology companies in Brittany

See 15 companies 
Pharmaceuticals & Biotechnology companies in Brittany

See 19 companies 
Companies in Nantes with revenue in $5.0-25M range

See 43 companies 
Companies in Brittany with revenue in $5.0-25M range

See 82 companies 
Companies in Brittany with employees in 1-25 range

See 118 companies 
Companies in Nantes with employees in 1-25 range

See 141 companies 
Biotechnology companies in France

See 813 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for InFlectis and InFlectis's Competitors

April 16, 2025Medthority
Sandoz files antitrust litigation against Amgen over etanercept biosimilar access....
April 15, 2025StreetInsider
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...
April 15, 2025Powder and Bulk Solids
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....

Frequently Asked Questions about InFlectis

  1. Who are InFlectis's top competitors?

    InFlectis's top 3 competitors are NMD Pharma, PepGen, Scholar Rock.

  2. Who is similar to InFlectis?

    NMD Pharma is the most similar to InFlectis. PepGen and Scholar Rock are also similar to InFlectis.

  1. Are InFlectis and NMD Pharma competitors?

    Yes, NMD Pharma is one of InFlectis’s top competitors.